Elanco Animal Health Inc Quarterly Costs and Expenses in USD from Q3 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Elanco Animal Health Inc quarterly/annual Costs and Expenses history and growth rate from Q3 2017 to Q2 2024.
Elanco Animal Health Inc Costs and Expenses for the quarter ending June 30, 2024 was $1.22B, a 7.04% increase year-over-year.
Elanco Animal Health Inc Costs and Expenses for the twelve months ending June 30, 2024 was $5.74B, a 29.5% increase year-over-year.
Elanco Animal Health Inc annual Costs and Expenses for 2023 was $5.61B, a 25.2% increase from 2022.
Elanco Animal Health Inc annual Costs and Expenses for 2022 was $4.48B, a 16% decline from 2021.
Elanco Animal Health Inc annual Costs and Expenses for 2021 was $5.34B, a 35.1% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$5.74B	$1.22B	+$80M	+7.04%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$5.66B	$1.19B	+$44M	+3.83%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$5.61B	$1.16B	+$89M	+8.3%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-26
Q3 2023	$5.52B	$2.17B	+$1.1B	+102%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$4.43B	$1.14B	-$53M	-4.46%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$4.48B	$1.15B	-$2M	-0.17%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$4.48B	$1.07B	-$164M	-13.3%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-26
Q3 2022	$4.65B	$1.07B	-$191M	-15.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$4.84B	$1.19B	-$326M	-21.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	$5.16B	$1.15B	-$171M	-12.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	$5.34B	$1.24B	-$223M	-15.3%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-26
Q3 2021	$5.56B	$1.26B	+$162M	+14.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$5.4B	$1.52B	+$852M	+129%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$4.54B	$1.32B	+$596M	+82.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	$3.95B	$1.46B	+$669M	+84.5%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	$3.28B	$1.1B	+$315M	+40.2%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	$2.96B	$663M	-$68.4M	-9.35%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$3.03B	$726M	+$39.7M	+5.79%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-07
Q4 2019	$2.99B	$792M	-$10M	-1.25%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-28
Q3 2019	$3B	$784M	+$102M	+14.9%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	$2.9B	$731M	-$78.8M	-9.73%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-30
Q1 2019	$2.98B	$686M	+$27.6M	+4.19%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$2.95B	$802M			Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018		$682M	-$23.9M	-3.38%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-08
Q2 2018		$810M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-13
Q1 2018		$659M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-14
Q3 2017		$706M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.